<?xml version="1.0" ?>
<document id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a">
  <chunk id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0" text="Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB">
    <entity charOffset="0-9" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0.e0" ontology_id="HP_0012115" text="Hepatitis" type="phenotype"/>
    <entity charOffset="52-68" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0.e1" ontology_id="GO_0043235" text="receptor complex" type="gene_function"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0.e1" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c0.p0" relation="true"/>
  </chunk>
  <chunk id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1" text="Hepatitis C virus (HCV) and the malaria parasite Plasmodium use the membrane protein CD81 to invade human liver cells. Here we mapped 33 host protein interactions of CD81 in primary human liver and hepatoma cells using high-resolution quantitative proteomics. In the CD81 protein network, we identified five proteins which are HCV entry factors or facilitators including epidermal growth factor receptor (EGFR). Notably, we discovered calpain-5 (CAPN5) and the ubiquitin ligase Casitas B-lineage lymphoma proto-oncogene B (CBLB) to form a complex with CD81 and support HCV entry. CAPN5 and CBLB were required for a post-binding and pre-replication step in the HCV life cycle. Knockout of CAPN5 and CBLB reduced susceptibility to all tested HCV genotypes, but not to other enveloped viruses such as vesicular stomatitis virus and human coronavirus. Furthermore, Plasmodium sporozoites relied on a distinct set of CD81 interaction partners for liver cell entry. Our findings reveal a comprehensive CD81 network in human liver cells and show that HCV and Plasmodium highjack selective CD81 interactions, including CAPN5 and CBLB for HCV, to invade cells.">
    <entity charOffset="0-9" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e0" ontology_id="HP_0012115" text="Hepatitis" type="phenotype"/>
    <entity charOffset="68-76" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e1" ontology_id="GO_0016020" text="membrane" type="gene_function"/>
    <entity charOffset="381-387" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e2" ontology_id="GO_0040007" text="growth" type="gene_function"/>
    <entity charOffset="461-470" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e3" ontology_id="GO_0031386" text="ubiquitin" type="gene_function"/>
    <entity charOffset="496-504" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e4" ontology_id="HP_0002665" text="lymphoma" type="phenotype"/>
    <entity charOffset="808-818" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e5" ontology_id="HP_0010280" text="stomatitis" type="phenotype"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e1" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p0" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e2" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p1" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e3" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p2" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e1" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p3" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e1" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e5" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p4" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e2" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p5" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e2" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e5" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p6" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e3" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p7" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e3" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.e5" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c1.p8" relation="true"/>
  </chunk>
  <chunk id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2" text="Author summary CD81 is a cell membrane protein, which functions as entry factor for hepatitis C virus (HCV) and malaria sporozoites in the human liver. Currently, it remains enigmatic how CD81 guides the entry process of both pathogens and whether it functions in a similar way during liver cell invasion of HCV and malaria parasites. Here, we use high resolution quantitative proteomics to identify CD81 associated host proteins in liver cells. We found that at least 33 proteins form a complex with CD81, 23 of which were not reported as interaction partners before. We further determined that at least five CD81 interactors are PLOS Pathogens | https://doi..mh-hannover.de/zib_zib.html) to JB, grants HCV host factors, among them calpain-5 (CAPN5) and the ubiquitin ligase Casitas Blineage lymphoma proto-oncogene B (CBLB). All tested HCV genotypes require CAPN5 and CBLB for full infection, but neither malaria parasites nor other tested enveloped virus rely on CAPN5 or CBLB. Our study maps the liver cell interactome of CD81 and provides new insight into the distinct cell invasion mechanisms of HCV and malaria parasites.">
    <entity charOffset="25-38" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e0" ontology_id="GO_0005886" text="cell membrane" type="gene_function"/>
    <entity charOffset="30-38" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e1" ontology_id="GO_0016020" text="membrane" type="gene_function"/>
    <entity charOffset="84-93" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e2" ontology_id="HP_0012115" text="hepatitis" type="phenotype"/>
    <entity charOffset="759-768" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e3" ontology_id="GO_0031386" text="ubiquitin" type="gene_function"/>
    <entity charOffset="793-801" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e4" ontology_id="HP_0002665" text="lymphoma" type="phenotype"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e2" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p0" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e0" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p1" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e1" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e2" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p2" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e1" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p3" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e2" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e3" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p4" relation="true"/>
    <pair e1="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e3" e2="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.e4" id="ddba9808c2e5a41e0a27996ff5b59e4c09ae159a.c2.p5" relation="true"/>
  </chunk>
</document>
